MAnnitol for Blood Pressure Stability in HemoDialysis (MAP-HD)
Status:
Recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
This proposal will measure the effects of mannitol administration versus placebo in
hypotensive-prone, adult, maintenance hemodialysis patients with respect to changes in
patient symptoms and blood pressure stability.